Haselmeier Announces The Market Launch Of Juniorstarreg By Sanofizurich Switzerland 03 April 2014 Ndash The New And Reusable Halfunit Insulin Penjuniorstarreg Is Now Available In Germany It Is Suitable For All Insulin Types Of Sanofi It Providesindividual Dosage Which Can Be Corrected Easily Furthermore It Has A Large Display To Ensurethe Correct Dosage And Is A Lightweight Companion During The Day Especially For Young Peoplewith Diabetesquotthe Launch Of Juniorstarreg Marks Another Milestone Of A Longterm Partnership With Sanofiafter The Single Unit Pen Tactipenreg The Portfolio Is Now Completed By The Halfunit Penjuniorstarreg The Juniorstarreg Delivers 1 To 30 Units In Steps Of 05 Thanks To The Closecooperation Of Both Teams We Were Able To Develop An Excellent Pen Which Meets The Currentvery High Quality Requirementsquot Explains Sandra De Haan Director Project Management Athaselmeier And Responsible Project Manager For The Juniorstarreg Projectquotthe Juniorstarreg Expands Our Individual Portfolio For People Suffering From Diabetes This Penoffers Especially Young People With Type 1 Diabetes A Flexible And Easy Handling To Lightentheir Lives With Diabetes The Excellent And Close Cooperation With Haselmeier Was An Importantpart For The Successful Development Of The Juniorstarreg Penquot Explains Hamit Oualali Globaldevice Manager For Reusable Pens At Sanofithis Pen Comes In Red Blue And Silver For More Flexibility And Easy Differentiation Of Variousinsulin Typesthe Chicago Athenaeum Museum Of Architecture And Design Already Honoured The Juniorstarregpen For Its New And Fully Developed Technology With The Good Design Awardabout Sanofisanofiaventis Deutschland Gmbh Is A Company Of The Sanofi Group A Global Healthcareleader Which Discovers Develops And Distributes Therapeutic Solutions To Meet The Patients39needs Sanofi Has Its Core Strengths In The Field Of Healthcare With Seven Growth Platformsdiabetes Solutions Vaccines Innovative Medication Overthecounter Health Care Productsemerging Markets Animal Health And Genzymeabout Haselmeierfounded In Stuttgart In 1920 Haselmeier Is Now One Of The Leading Designers Andmanufacturers Of Injection Systems The Devices Feature Unique Function Design And Technologyand Are Marketed By Leading Pharmaceutical And Biotechnology Companies Around The Worldlocated In Five Locations Across Three Continents We Develop And Produce Innovativetechnologies For Administering Medication To Improve The Health And Everyday Life Of Patientsplease Find Further Information Under Wwwhaselmeiercomcontacthaselmeier Gmbhdufourstrasse 328008 Zurichswitzerlandnadia Di Secli Marketing Managertel 41 44 250 58 50nseclihaselmeiercom
